Array BioPharma: National Comprehensive Cancer Network, FDA OKs drug combo for melanoma

Array BioPharma: National Comprehensive Cancer Network, FDA OKs drug combo for melanoma

BOULDER -- Array BioPharma Inc. (Nasdaq: ARRY) announced that the National Comprehensive Cancer Network (NCCN) has updated the Clinical Practice Guidelines in Oncology for Melanoma to include... Read More

Monday July 16, 2018 0 comments Tags: Boulder, Array BioPharma, melanoma, Ron Squarer, FDA

Biodesix: New clinical findings show diagnostic advances for novel drug

Biodesix: New clinical findings show diagnostic advances for novel drug

BOULDER -- Biodesix Inc . announced new clinical findings that show its novel investigational test, BDX008 based on profiling serum proteins identifies patients with advanced melanoma who are... Read More

Tuesday November 10, 2015 0 comments Tags: Boulder, Biodesix, Richard Hockett, melanoma, nivolumab